Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Newcombe

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Pathology|June 23, 2022
Molecular typing of enteroviruses: comparing 5'UTR, VP1 and whole genome sequencing methodsT Gulholm, M Yeang, I Nguyen, et al.
Eclinicalmedicine|May 4, 2022
Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohortAdam Hampshire, Doris A Chatfield, Anne Manktelow MPhil, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2008
Discovery of a novel class of 2-ureido thiophene carboxamide checkpoint kinase inhibitorsJames W Janetka, Lynsie Almeida, Susan Ashwell, et al.
Ebiomedicine|December 27, 2021
Relationship of admission blood proteomic biomarkers levels to lesion type and lesion burden in traumatic brain injury: A CENTER-TBI studyDaniel P Whitehouse, Miguel Monteiro, Endre Czeiter, et al.
Intensive Care Medicine|June 20, 2022
Correction to: Management of moderate to severe traumatic brain injury: an update for the intensivistGeert Meyfroidt, Pierre Bouzat, Michael P Casaer, et al.
Intensive Care Medicine|May 20, 2022
Management of moderate to severe traumatic brain injury: an update for the intensivistGeert Meyfroidt, Pierre Bouzat, Michael P Casaer, et al.
Brain : a Journal of Neurology|April 4, 2022
Post-acute blood biomarkers and disease progression in traumatic brain injuryVirginia F J Newcombe, Nicholas J Ashton, Jussi P Posti, et al.
Journal of Medicinal Chemistry|June 27, 2014
Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonistsWilliam McCoull, Peter Barton, Alastair J H Brown, et al.
Scientific Reports|August 25, 2017
Homozygous p.Ser267Phe in SLC10A1 is associated with a new type of hypercholanemia and implications for personalized medicineRuihong Liu, Chuming Chen, Xuefeng Xia, et al.
Global Spine Journal|March 25, 2024
A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on Hemodynamic ManagementBrian K Kwon, Lindsay A Tetreault, Allan R Martin, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Pathology|June 23, 2022
Molecular typing of enteroviruses: comparing 5'UTR, VP1 and whole genome sequencing methodsT Gulholm, M Yeang, I Nguyen, et al.
Eclinicalmedicine|May 4, 2022
Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohortAdam Hampshire, Doris A Chatfield, Anne Manktelow MPhil, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2008
Discovery of a novel class of 2-ureido thiophene carboxamide checkpoint kinase inhibitorsJames W Janetka, Lynsie Almeida, Susan Ashwell, et al.
Ebiomedicine|December 27, 2021
Relationship of admission blood proteomic biomarkers levels to lesion type and lesion burden in traumatic brain injury: A CENTER-TBI studyDaniel P Whitehouse, Miguel Monteiro, Endre Czeiter, et al.
Intensive Care Medicine|June 20, 2022
Correction to: Management of moderate to severe traumatic brain injury: an update for the intensivistGeert Meyfroidt, Pierre Bouzat, Michael P Casaer, et al.
Intensive Care Medicine|May 20, 2022
Management of moderate to severe traumatic brain injury: an update for the intensivistGeert Meyfroidt, Pierre Bouzat, Michael P Casaer, et al.
Brain : a Journal of Neurology|April 4, 2022
Post-acute blood biomarkers and disease progression in traumatic brain injuryVirginia F J Newcombe, Nicholas J Ashton, Jussi P Posti, et al.
Journal of Medicinal Chemistry|June 27, 2014
Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonistsWilliam McCoull, Peter Barton, Alastair J H Brown, et al.
Scientific Reports|August 25, 2017
Homozygous p.Ser267Phe in SLC10A1 is associated with a new type of hypercholanemia and implications for personalized medicineRuihong Liu, Chuming Chen, Xuefeng Xia, et al.
Global Spine Journal|March 25, 2024
A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on Hemodynamic ManagementBrian K Kwon, Lindsay A Tetreault, Allan R Martin, et al.
Pageof 20